Hiru Corporation

Hiru Corporation: New Agreement To Bring $1.5 Million USD Annually FUZHOU CITY, CHINA, Hiru Corporation (HIRU; http://www.hirucorporation.com/) and its subsidiary Jiangxi RongYu Pharmaceutical Group, Inc. (http://www.jxrongyuyy.com/) signed an agreement with the National Forestry Academy to jointly develop a Gutta Percha tree plantation. The agreement also extends to the purchase of company's existing Eucommia tree products. The agreement binds RongYu Pharmaceutical and the National Forestry Academy to jointly develop Gutta Percha tree plantation for industrial use. The National Forestry Academy developed patented technology for production of Gutta Percha. Gutta Percha tree, native to South-East Asia, produces sap used for latex production, and manufactures commonly use this form of latex to make car tires. Further, the agreement also extends to the industrial use of Jiangxi RongYu Eucommia tree products. Jiangxi RongYu Pharmaceutical recently build Eucommia tree plantation on almost 20 acres of land, and agreement involves purchase of these products for industrial use. Jiangxi RongYu expects that this important strategic cooperation agreement will raise the company's annual income, yielding approximately $1.5 million USD or 10 million RMB annually.

KLYG.pk - Kelyniam Global, Inc. - New News Release

KLYG - Kelyniam Global, Inc.

 

Kelyniam's Sales Team Signs Purchase Order With Major Insurance Provider

 
LITTLE ROCK, AR, Feb 23, 2010  -- Kelyniam Global, Inc.  announces today that Synergy Surgical, LLC, a company Kelyniam recently teamed up with to sell its custom implants, has signed a purchase order with Kaiser Permanente Oakland Medical Center. On January 26, 2010 a sales team from Synergy Surgical presented Kelyniam's Custom Cranial implants to trauma surgeons at Children's Hospital in Oakland, California. Based on design, quality, price and turnaround time, Children's Hospital surgeons agreed to have Kelyniam provide all future custom cranial implants.
Jon Giannini, Synergy Surgical Owner and Managing Partner, stated: "What makes Kelyniam's product so attractive is their pricing and turnaround time. We have not seen a manufacturer in this discipline that can turn the product around from the receipt of the CT data to the delivery of the implant in the time Kelyniam can. This unmatched attention to each unique surgery translates into better patient care."
Synergy Surgical will be expanding its sales territory in the near future, and Kelyniam will be providing Custom Implants to the additional hospitals. Kelyniam's current capacity is about 1,500 units per year.
Please see Kelyniam's latest video at www.kelyniam.com/medicalvideo.asp for more information about Kelyniam's medical products.
More information about Kelyniam Global, Incorporated:
Kelyniam Global, Inc. is a balanced vertically-integrated company that services a vast array of clients across numerous fields and industries encompassing, but not limited to, medical, automotive, aerospace, jewelry, nautical and consumer products. The company specializes in the use of CADCAM technology with recent developments in the production of high precision replication of artificial bone implants for medical applications.